Evidence map›Paper›PMID 25139764›Full record

ArticleAAPS PharmSciTech2014

Photodegradation of moxifloxacin in aqueous and organic solvents: a kinetic study.

Iqbal Ahmad, Raheela Bano, Syed Ghulam Musharraf, Sofia Ahmed, Muhammad Ali Sheraz, Qamar ul Arfeen, Muhammad Salman Bhatti, Zufi Shad

Abstract readValidation Study
In one paragraph

Article in AAPS PharmSciTech, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Iqbal AhmadBaqai Institute of Pharmaceutical Sciences, Baqai Medical University, Toll Plaza, Super highway, Gadap Road, Karachi, 74600, Pakistan.
Raheela Bano
Syed Ghulam Musharraf
Sofia Ahmed
Muhammad Ali Sheraz
Qamar ul Arfeen
Muhammad Salman Bhatti
Zufi Shad

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The kinetics of photodegradation of moxifloxacin (MF) in aqueous solution (pH 2.0-12.0), and organic solvents has been studied. MF photodegradation is a specific acid-base catalyzed reaction and follows first-order kinetics. The apparent first-order rate constants (kobs) for the photodegradation of MF range from 0.69 × 10(-4) (pH 7.5) to 19.50 × 10(-4) min(-1) (pH 12.0), and in organic solvents from 1.24 × 10(-4) (1-butanol) to 2.04 × 10(-4) min(-1) (acetonitrile). The second-order rate constant (k2) for the [H(+)]-catalyzed and [OH(-)]-catalyzed reactions are 6.61 × 10(-2) and 19.20 × 10(-2) M(-1) min(-1), respectively. This indicates that the specific base-catalyzed reaction is about three-fold faster than that of the specific acid-catalyzed reaction probably as a result of the rapid cleavage of diazabicyclononane side chain in the molecule. The kobs-pH profile for the degradation reactions is a V-shaped curve indicating specific acid-base catalysis. The minimum rate of photodegradation at pH 7-8 is due to the presence of zwitterionic species. There is a linear relation between kobs and the dielectric constant and an inverse relation between kobs and the viscosity of the solvent. Some photodegraded products of MF have been identified and pathways proposed for their formation in acid and alkaline solutions.

Indexed as

LightPhotolysisAnti-Bacterial AgentsChemistry, PharmaceuticalChromatography, High Pressure LiquidDrug StabilityFluoroquinolonesHydrogen-Ion ConcentrationKineticsLinear ModelsModels, ChemicalMoxifloxacinOrganic ChemicalsReproducibility of ResultsSolventsSpectrometry, Mass, Electrospray IonizationAnti-Bacterial AgentsFluoroquinolonesMoxifloxacinOrganic ChemicalsSolvents

Identifiers

PMID25139764
PMCPMC4245426

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.